Abstract
Placental (PLAP) and germ-cell (GCAP) alkaline phosphatases are inhibited uncompetitively by L-Leu and L-Phe. Whereas L-Phe inhibits PLAP and GCAP to the same extent, L-Leu inhibits GCAP 17-fold more strongly than it does PLAP. This difference has been attributed [Hummer & Millán (1991) Biochem. J 274, 91-95] to a Glu----Gly substitution at position 429 in GCAP. The D-Phe and D-Leu enantiomorphs are also inhibitory through an uncompetitive mechanism but with greatly decreased efficiencies. Replacement of the active-site residue Arg-166 by Ala-166 changes the inhibition mechanism of the resulting PLAP mutant to a more complex mixed-type inhibition, with decreased affinities for L-Leu and L-Phe. The uncompetitive mechanism is restored on the simultaneous introduction of Gly-429 in the Ala-166 mutant, but the inhibitions of [Ala166,Gly429]PLAP and even [Lys166,Gly429]PLAP by L-Leu and L-Phe are considerably decreased compared with that of [Gly429]PLAP. These findings point to the importance of Arg-166 during inhibition. Active-site binding of L-Leu requires the presence of covalently bound phosphate in the active-site pocket, and the inhibition of PLAP by L-Leu is pH-sensitive, gradually disappearing when the pH is decreased from 10.5 to 7.5. Our data are compatible with the following molecular model for the uncompetitive inhibition of PLAP and GCAP by L-Phe and L-Leu: after binding of a phosphorylated substrate to the active site, the guanidinium group of Arg-166 (normally involved in positioning phosphate) is redirected to the carboxy group of L-Leu (or L-Phe), thus stabilizing the inhibitor in the active site. Therefore leucinamide and leucinol are weaker inhibitors of [Gly429]PLAP than is L-Leu. During this Arg-166-regulated event, the amino acid side group is positioned in the loop containing Glu-429 or Gly-429, leading to further stabilization. Replacement of Glu-429 by Gly-429 eliminates steric constraints experienced by the bulky L-Leu side group during its positioning and also increases the active-site accessibility for the inhibitor, providing the basis for the 17-fold difference in inhibition efficiency between PLAP and GCAP. Finally, the inhibitor's unprotonated amino group co-ordinates with the active-site Zn2+ ion 1, interfering with the hydrolysis of the phosphoenzyme intermediate, a phenomenon that determines the uncompetitive nature of the inhibition.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bird P., Gething M. J., Sambrook J. Translocation in yeast and mammalian cells: not all signal sequences are functionally equivalent. J Cell Biol. 1987 Dec;105(6 Pt 2):2905–2914. doi: 10.1083/jcb.105.6.2905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Butler-Ransohoff J. E., Kendall D. A., Kaiser E. T. Use of site-directed mutagenesis to elucidate the role of arginine-166 in the catalytic mechanism of alkaline phosphatase. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4276–4278. doi: 10.1073/pnas.85.12.4276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Byers D. A., Fernley H. N., Walker P. G. Studies on alkaline phosphatase. Inhibition of human-placental phosphoryl phosphatase by L-phenylalanine. Eur J Biochem. 1972 Sep 18;29(2):197–204. doi: 10.1111/j.1432-1033.1972.tb01975.x. [DOI] [PubMed] [Google Scholar]
- Chaidaroglou A., Brezinski D. J., Middleton S. A., Kantrowitz E. R. Function of arginine-166 in the active site of Escherichia coli alkaline phosphatase. Biochemistry. 1988 Nov 1;27(22):8338–8343. doi: 10.1021/bi00422a008. [DOI] [PubMed] [Google Scholar]
- Chaidaroglou A., Kantrowitz E. R. Alteration of aspartate 101 in the active site of Escherichia coli alkaline phosphatase enhances the catalytic activity. Protein Eng. 1989 Nov;3(2):127–132. doi: 10.1093/protein/3.2.127. [DOI] [PubMed] [Google Scholar]
- Doellgast G. J., Fishman W. H. L-leucine, a specific inhibitor of a rare human placental alkaline phosphatase phenotype. Nature. 1976 Jan 1;259(5538):49–51. doi: 10.1038/259049a0. [DOI] [PubMed] [Google Scholar]
- Fishman W. H. On the importance of being (stereo) specific. Clin Chim Acta. 1990 Jan 15;186(2):129–131. doi: 10.1016/0009-8981(90)90030-v. [DOI] [PubMed] [Google Scholar]
- Fishman W. H., Sie H. G. Organ-specific inhibition of human alkaline phosphatase isoenzymes of liver, bone, intestine and placenta; L-phenylalanine, L-tryptophan and L homoarginine. Enzymologia. 1971 Sep 30;41(3):141–167. [PubMed] [Google Scholar]
- Gasser K. W., Kirschner L. B. The inhibition and disposition of intestinal alkaline phosphatase. J Comp Physiol B. 1987;157(4):461–467. doi: 10.1007/BF00691830. [DOI] [PubMed] [Google Scholar]
- Ghosh N. K., Fishman W. H. On the mechanism of inhibition of intestinal alkaline phosphatase by L-phenylalanine. I. Kinetic studies. J Biol Chem. 1966 Jun 10;241(11):2516–2522. [PubMed] [Google Scholar]
- Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Green S., Anstiss C. L., Fishman W. H. Automated differential isoenzyme analysis. II. The fractionation of serum alkaline phosphatases into "liver", "intestinal" and "other" components. Enzymologia. 1971 Jul 31;41(1):9–26. [PubMed] [Google Scholar]
- Harris H. The human alkaline phosphatases: what we know and what we don't know. Clin Chim Acta. 1990 Jan 15;186(2):133–150. doi: 10.1016/0009-8981(90)90031-m. [DOI] [PubMed] [Google Scholar]
- Hoylaerts M. F., Millán J. L. Site-directed mutagenesis and epitope-mapped monoclonal antibodies define a catalytically important conformational difference between human placental and germ cell alkaline phosphatase. Eur J Biochem. 1991 Dec 5;202(2):605–616. doi: 10.1111/j.1432-1033.1991.tb16414.x. [DOI] [PubMed] [Google Scholar]
- Hummer C., Millán J. L. Gly429 is the major determinant of uncompetitive inhibition of human germ cell alkaline phosphatase by L-leucine. Biochem J. 1991 Feb 15;274(Pt 1):91–95. doi: 10.1042/bj2740091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jeppsson A., Wahren B., Brehmer-Andersson E., Silfverswärd C., Stigbrand T., Millán J. L. Eutopic expression of placental-like alkaline phosphatase in testicular tumors. Int J Cancer. 1984 Dec 15;34(6):757–761. doi: 10.1002/ijc.2910340604. [DOI] [PubMed] [Google Scholar]
- Kim E. E., Wyckoff H. W. Reaction mechanism of alkaline phosphatase based on crystal structures. Two-metal ion catalysis. J Mol Biol. 1991 Mar 20;218(2):449–464. doi: 10.1016/0022-2836(91)90724-k. [DOI] [PubMed] [Google Scholar]
- Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488–492. doi: 10.1073/pnas.82.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Millán J. L., Manes T. Seminoma-derived Nagao isozyme is encoded by a germ-cell alkaline phosphatase gene. Proc Natl Acad Sci U S A. 1988 May;85(9):3024–3028. doi: 10.1073/pnas.85.9.3024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Millán J. L. Molecular cloning and sequence analysis of human placental alkaline phosphatase. J Biol Chem. 1986 Mar 5;261(7):3112–3115. [PubMed] [Google Scholar]
- Millán J. L. Oncodevelopmental alkaline phosphatases: in search for a function. Prog Clin Biol Res. 1990;344:453–475. [PubMed] [Google Scholar]
- Millán J. L., Stigbrand T. Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies. Eur J Biochem. 1983 Oct 17;136(1):1–7. doi: 10.1111/j.1432-1033.1983.tb07697.x. [DOI] [PubMed] [Google Scholar]
- Mulivor R. A., Plotkin L. I., Harris H. Differential inhibition of the products of the human alkaline phosphatase loci. Ann Hum Genet. 1978 Jul;42(1):1–13. doi: 10.1111/j.1469-1809.1978.tb00927.x. [DOI] [PubMed] [Google Scholar]
- Paiva J., Damjanov I., Lange P. H., Harris H. Immunohistochemical localization of placental-like alkaline phosphatase in testis and germ-cell tumors using monoclonal antibodies. Am J Pathol. 1983 May;111(2):156–165. [PMC free article] [PubMed] [Google Scholar]
- Ramasamy I., Butterworth P. J. Nicotinamide-adenine dinucleotide inhibition of pig kidney alkaline phosphatase. Biochim Biophys Acta. 1975 Mar 28;384(1):146–158. doi: 10.1016/0005-2744(75)90104-7. [DOI] [PubMed] [Google Scholar]
- Ramasamy I., Butterworth P. J. The inhibition of pig kidney alkaline phosphatase by oxidized or reduced nicotinamide-adenine dinucleotide and related compounds. Biochem J. 1973 Feb;131(2):359–367. doi: 10.1042/bj1310359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sowadski J. M., Handschumacher M. D., Murthy H. M., Foster B. A., Wyckoff H. W. Refined structure of alkaline phosphatase from Escherichia coli at 2.8 A resolution. J Mol Biol. 1985 Nov 20;186(2):417–433. doi: 10.1016/0022-2836(85)90115-9. [DOI] [PubMed] [Google Scholar]
- Trotman C. N., Greenwood C. Effects of zinc and other metal ions on the stability and activity of Escherichia coli alkaline phosphatase. Biochem J. 1971 Aug;124(1):25–30. doi: 10.1042/bj1240025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WILKINSON G. N. Statistical estimations in enzyme kinetics. Biochem J. 1961 Aug;80:324–332. doi: 10.1042/bj0800324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- YONETANI T., THEORELL H. STUDIES ON LIVER ALCOHOL HYDROGENASE COMPLEXES. 3. MULTIPLE INHIBITION KINETICS IN THE PRESENCE OF TWO COMPETITIVE INHIBITORS. Arch Biochem Biophys. 1964 Jul 20;106:243–251. doi: 10.1016/0003-9861(64)90184-5. [DOI] [PubMed] [Google Scholar]